SS Innovations International (SSII) EBIT Growth (3y) (2019 - 2026)
SS Innovations International (SSII) EBIT Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | -50.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.35% |
| Dec 31, 2025 | 5.72% |
| Sep 30, 2025 | -62.79% |
| Jun 30, 2025 | 28.74% |
| Mar 31, 2025 | -319.20% |
| Dec 31, 2024 | -73.21% |
| Sep 30, 2024 | -97.16% |
| Jun 30, 2024 | -115.05% |
| Mar 31, 2024 | -220.01% |
| Dec 31, 2023 | -279.92% |
| Sep 30, 2023 | -70.27% |
| Jun 30, 2023 | -186.83% |
| Mar 31, 2023 | -51.70% |
| Dec 31, 2022 | 5.78% |
| Sep 30, 2022 | 19.20% |
| Jun 30, 2022 | -552.41% |
| Mar 31, 2022 | -43.60% |
| Dec 31, 2021 | -26.98% |
| Sep 30, 2021 | -79.41% |
| Jun 30, 2021 | -67.40% |